top of page
NEWS BLOG
Search


Advancing Gene Therapies & Enabling Disease Models
A joint conference of the GET-IN & LifeLUNG EU consortia. Submit abstracts by 22 November 2026.
Emma Clare
3 days ago1 min read


2026-HAMBURG
The 33rd ESGCT Annual Congress took place in collaboration with DG-GT from 27-30 October 2026 at the Congress Center Hamburg (CCH), in Hamburg. Congress delegates can log in to their online registration portal to access the Congress abstract book, online programme, and Certificate of Attendance. Login here > Abstracts published by Human Gene Therapy will be available soon. Event Statistics (Click to enlarge) We are very grateful for the support of all our sponsors and partner
Emma Clare
Nov 111 min read


Luigi Naldini elected as an international member to the National Academy of Medicine
Congratulations to Luigi Naldini, who has been elected as an international member to the NAM.
Emma Clare
Oct 291 min read


R2-I Recognised Researcher (Therapeutics and innovations in neuropediatrics) - Vall D'Hebron, Barcelona
The Research Group “Therapeutics and Innovations in Neuropediatrics” at Vall d'Hebron Research Institute (VHIR) is seeking a motivated Postdoctoral Researcher to join a translational research project focused on therapy development for LAMA2-related muscular dystrophy (LAMA2-RD). The selected candidate will contribute to preclinical studies aimed at evaluating innovative therapeutic strategies, including cell-based approaches and/or studies in mouse models of disease. More
Gaëlle Jamar
Oct 191 min read


SR-TIGET–Danaher Symposium, “Unlocking Access: Cell & Gene Therapy at Scale ” San Raffaele Hospital in Milan on 9–10 November 2026
SR-TIGET–Danaher Symposium, “Unlocking Access: Cell & Gene Therapy at Scale ” is taking place at San Raffaele Hospital in Milan on 9–10 November 2026, marking the 30th anniversary of SR-TIGET. The meeting will bring together leading researchers, clinicians, industry experts and patient representatives to discuss advances in hematopoietic stem cell gene therapy and genome editing, alongside key challenges in safety, manufacturing and sustainable patient access. The symposium w
Gaëlle Jamar
Oct 131 min read


Priora is hiring – 5 scientific roles in immune-cell delivery for neurological disease, London, UK
Priora is an early-stage company building a delivery route for therapies to the brain, using engineered immune cells to reach specific cell subsets non-invasively. The team of ~15 researchers is based in London and San Francisco. Open roles, all London and full-time: VP of Translational Research; Senior Scientist, In Vivo Neuroscience; Senior Computational Scientist; Research Scientist, In Vitro; and Scientist, Mouse Models. Full details and application links for each role ar
Gaëlle Jamar
Sep 181 min read


T2EVOLVE Association Launches to Advance Collaboration and Innovation in Advanced Cell Therapies Across Europe
For more information, clic here
carojamar
Jul 61 min read


EXCEPTIONAL SERVICE AWARD
This new award has been created to recognise individuals for their outstanding contribution to ESGCT's mission to advance knowledge.
Gaëlle Jamar
Jul 21 min read


2026-SPRING SCHOOL COIMBRA
The 9th ESGCT Spring School took place in Coimbra, Portugal from 14-17 April 2026. The Spring School was jointly organised with the the Gene Therapy Center of Excellence Portugal (GeneT). Spring School attendees can log in to their registration portal to access their registration details, event resources and certificates of attendance via the link below.
Emma Clare
Jun 81 min read


2026-HAMBURG
Join us for the 33rd ESGCT Annual Congress, which takes place in collaboration with DG-GT from 27-30 October 2026 at the Congress Center Hamburg, Germany.
Emma Clare
May 151 min read


ESGCT Expert Interview - Claire Booth
View Claire's biography below 1. What advice do you wish you had received at both the start and the conclusion of your PhD journey? Be open to change — your original plan might evolve, but the learning along the way is just as valuable. Expect setbacks — it’s is a safe space to make mistakes, so treat them as part of the process, not as failures. The experience is as much about training and developing your skills as it is about producing results. Start writing up before
Emma Clare
Apr 203 min read


MOOC on gene and gene-based cell therapies for rare diseases
Foundation For Rare Diseases (Fondation Maladies Rares, France) organises an online MOOC on gene and gene-based cell therapies for rare diseases . The course features contributions from leading U.S. and European researchers — including Alain Fischer, Heather Gray Edwards, Alessio Cantore, Zoltan Ivics, Sylvie Odent, Salima Hacein-Bey-Abina, Manuel Gonçalves, Marina Cavazzana, Allison Bradbury, Anne Galy, Chantal Pichon, Claire Booth, Jeffrey Medin , among others — as well a
carojamar
Apr 102 min read


In memory of Professor Claudio Bordignon
ESGCT are greatly saddened by the loss of Professor Claudio Bordignon, a pioneer in the gene therapy field, and the first President of the ESGCT.
Emma Clare
Apr 11 min read


FDA approval of LAD gene therapy
Last Thursday, the FDA approved the LAD gene therapy developed by Juan A. Bueren and Elena Almarza, in collaboration with the Adrian Thrasher team. This treatment was licensed to Rocket Pharma, who developed the clinical trial and presented it to the FDA. We believe this is terrific news for the gene therapy field and for ESGCT, as all these advances have come from ESGCT members, and the society has played a fundamental role in favouring this collaboration and in the developm
Gaëlle Jamar
Mar 301 min read


Emma Clare
Mar 270 min read


Emma Clare
Mar 270 min read


Around the World: Global Seminar Series Australasia - Thursday 26 February 2026
Hosted as part of the AROUND THE WORLD SERIES in collaboration with the Coalition of International Gene Therapy Societies.
Gaëlle Jamar
Feb 251 min read


ZELIG ESHAR ADOPTIVE T-CELL THERAPY YOUNG INVESTIGATOR AWARD
The Early Career Investigator Award recognises contributions made by ECRs.
Gaëlle Jamar
Feb 91 min read


OUTSTANDING ACHIEVEMENT AWARD
This award is given each year to an individual or a team who has made a significant impact in the field of gene and cell therapy.
Christina Slater
Feb 91 min read


ESGCT FOUNDERS AWARD
The Founders Award is given to an ESGCT senior scientist to celebrate key discoveries in gene and cell therapies.
Gaëlle Jamar
Feb 81 min read
bottom of page